Search

everythinglearnresearchcommunity

for

Search:↓

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Patients with renal disease should be cautious with vitamin A supplements due to risk of toxicity.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

Alopecia areata patients have eye issues and need regular eye exams.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Patients with renal disease may develop vitamin A toxicity even with low-dose supplements.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

A3 antibody helps identify key cells in rat hair follicle development.

Serum calprotectin is not a reliable marker for alopecia areata activity.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

JAK inhibitors may help improve symptoms in adults with APECED.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

Interleukin-15 can help hair growth and protect hair follicles.

An 8-year-old girl has a rare, irreversible hair loss condition caused by a genetic mutation.

A new sheep gene, KRTAP36-1, may help breed sheep with better wool by reducing prickle factor.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

The enzyme PA-PLA1α is important for proper hair follicle development.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

miR-155 levels in blood could help identify alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.